Showing results (261-270 of 500) with videos related to
Sort By:
Pageof 50
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.Journal of Immunological Methods|April 25, 2009
Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapyJacob A Klapper, Armen A Thomasian, Douglas M Smith, et al.Nature Genetics|September 1, 2009
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4Todd D Prickett, Neena S Agrawal, Xiaomu Wei, et al.Human Gene Therapy|October 24, 2009
Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cellsMarc R Theoret, Cyrille J Cohen, Azam V Nahvi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinaseTimothy L Frankel, William R Burns, Peter D Peng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2012
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanomaPeter A Prieto, James C Yang, Richard M Sherry, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinomaRichard E Royal, Catherine Levy, Keli Turner, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2018
Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain MetastasesGautam U Mehta, Parisa Malekzadeh, Thomas Shelton, et al.Journal of Autism and Developmental Disorders|August 28, 2016
Brief Report: Prevalence of Self-injurious Behaviors among Children with Autism Spectrum Disorder-A Population-Based StudyGnakub N Soke, Steven A Rosenberg, Richard F Hamman, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivoDaniel J Powell, Aloisio Felipe-Silva, Maria J Merino, et al.Pageof 50